Taiho Oncology

Develops and sells oral cancer medications for various tumors.

PharmaceuticalsBiotechnology taihooncology.com ↗

Company facts

Founded
2002
Employees
350
Headquarters
United States
Type
Public
Listed
Tokyo Stock Exchange: 4578
Subsidiaries
Taiho Oncology Europe, Taiho Pharma Canada